Ophthalmic pathology is the specialized branch of pathology focused on diseases and conditions affecting the eye and its adnexa. This field encompasses a wide range of disorders, including neoplastic, infectious, inflammatory, and degenerative conditions. Key aspects involve the microscopic examination of ocular tissues to diagnose diseases such as retinoblastoma, melanoma, and conjunctival neoplasms. Additionally, ophthalmic pathologists study conditions like uveitis, keratitis, and diabetic retinopathy. With advancements in molecular pathology, genetic mutations linked to ocular diseases are increasingly identified, aiding in targeted therapies. The integration of histopathological findings with clinical data is crucial for accurate diagnosis and effective treatment planning, ensuring optimal patient outcomes in ophthalmology.
Two autopsy studies of optic nerves from 76 eyes of abusive head trauma (AHT) suspects demonstrated block of orthograde axonal transport in the lamina cribrosa (LC) in 94% of cases by APP-A4…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Ophthalmic Pathology work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Ophthalmic Pathology research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Ophthalmic Pathology track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Ophthalmic Pathology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Ophthalmic Pathology are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Ophthalmic Pathology track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
